“…96,97 Twenty-four patients with mucocutaneous disease were treated with cyclosporine 5 mg/kg/day (reduced to cyclosporine 2.5 mg/kg/day if the serum creatinine increased by 33%) for a minimum of 6 months in an open-label study. 98 This study showed that cyclosporine improved oral ulcerations (18 patients had improvement, with 6 showing no evident oral ulcerations during the treatment period), genital ulcerations (17 of 21 patients had no genital ulcers during the study, one had a reduction in the genital lesions, one had stable disease, and two had worsening), acneiform lesions (17 of 18 patients had no lesions), erythema nodosumelike lesions (17 of 21 patients had no new lesions), and thrombophlebitis-like lesions (6 of 6 patients had resolution). Also, no new ocular attacks were seen in 11 of 14 patients, and arthralgias improved in three of six patients treated with cyclosporine.…”